Root Insurance leverages strategic partnerships to drive robust revenue growth in the insurtech sector. Despite notable income growth, market sentiment has turned cautious on ROOT's long-term growth ...

The actress, 46, suffered a traumatic brain injury in May after fainting while at a beach and falling face first into a boulder Bailey Richards is a writer-reporter at PEOPLE. She has been working at ...

In a decade, Eli Lilly could be in the same place that Pfizer finds itself in today. The big story around Eli Lilly is the success of its GLP-1 drugs Mounjaro (for diabetes) and Zepbound (for weight ...

Choosing a car insurance provider can be challenging. If you're considering Root, reviewing its rates will help determine if it's the right fit for your needs. However, we recommend collecting quotes ...

One of Eli Lilly’s most promising new obesity drugs helped patients lose about 28.7% of their body weight while also reducing pain associated with knee osteoarthritis. The drug giant’s LLY stock was ...

A next-generation obesity shot from Eli Lilly & Co. helped patients lose almost a quarter of their body weight, potentially making the experimental drug the most potent weight-loss medicine yet. The ...

Eli Lilly LLY-0.58%decrease; red down pointing triangle said its next generation weight-loss drug retatrutide helped people lose up to 28.7% of their body weight after more than a year of treatment, ...

Eli Lilly and Company (NYSE:LLY) is included among the 15 Best Stocks to Buy for the Long Term. Eli Lilly and Company (NYSE:LLY)’s popular drug Mounjaro will be added to China’s state-run health ...

Eli Lilly said it will spend $6 billion to build a manufacturing plant in Huntsville, Alabama, to help boost production of its closely watched experimental obesity pill, orforglipron, and other drugs.

HUNTSVILLE, Ala. (WAFF) - During a press conference held on Tuesday, pharmaceutical giant Eli Lilly announced that they will construct a $6 billion state-of-the-art pharmaceutical manufacturing plant ...

SHANGHAI, Dec 8 (Reuters) – Eli Lilly and Co.’s popular drug Mounjaro will be added to China’s state-run health insurance scheme from Jan. 1 for patients with type 2 diabetes, the National Healthcare ...

SHANGHAI, Dec 8 (Reuters) - Eli Lilly's (LLY.N), opens new tab popular drug Mounjaro will be added to China's state-run health insurance scheme from January 1 for patients with type 2 diabetes, the ...